<DOC>
<DOCNO>
EP-0015038
</DOCNO>
<TEXT>
<DATE>
19800903
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 A61P-25/00 C07D-233/76 C07D-233/86 <main>A61K-31/415</main> C07D-233/72 A61K-31/4166 A61K-31/4164 C07D-233/74 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation.
</TITLE>
<APPLICANT>
wallone regionbe<sep>region wallonne representee par le ministre des technologies nouvelles de la region wallonne<sep>region wallonne représentée par le ministre des technologies nouvelles de la region wallonneavenue des arts, 19 hb-1040 bruxellesbe<sep>region wallonne representee par le ministre des technologies nouvelles de la region wallonne <sep>
</APPLICANT>
<INVENTOR>
dumont pierre<sep>poupaert jacques<sep>dumont, pierre<sep>poupaert, jacques<sep>dumont, pierre13, avenue moine olbertb-5800 gemblouxbe<sep>poupaert, jacquesrue du palier, 22b-1348 ottigniesbe<sep>dumont, pierre <sep>poupaert, jacques  <sep>dumont, pierre13, avenue moine olbertb-5800 gemblouxbe<sep>poupaert, jacquesrue du palier, 22b-1348 ottigniesbe<sep>
</INVENTOR>
<ABSTRACT>
pharmaceutical composition, particularly psychotropic, comprising, as active component, a deuterine phenylhydantoin responding to the general formula: wherein the radicals R₁ are identical or different and represent a hydrogen atom or a methyl group, R₂ represents an ethyl group or a Phenyl substituted or non-deberte or not, R₁ represents a hydrogen or halogen atom or a linear or branched alkyl radical comprising 1 to 4 carbon atms, a linear or branched alkoxy radical comprising 1 to 4 carbon atoms, a trifluoromethyl, hydroxy, nitro or amino radical, X represents an oxo, thio or methylene group and X represents an integer between 1 and 5, one of its enantiomers, or one of its salts with a base physiologically acceptable, in combination with an acceptable pharmaceutical vehicle. (R, R, S), (R) and (s) -5-phenylhydantoin and their preparation processes.
</ABSTRACT>
</TEXT>
</DOC>
